These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24354899)

  • 21. The selection of children and adolescents for treatment with continuous subcutaneous insulin infusion (CSII).
    Fisher LK
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():11-4. PubMed ID: 16774612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of continuous insulin infusion pumps in young children with type 1 diabetes: a systematic review.
    Churchill JN; Ruppe RL; Smaldone A
    J Pediatr Health Care; 2009; 23(3):173-179. PubMed ID: 19401250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of guided self-determination youth intervention integrated into outpatient visits versus treatment as usual on glycemic control and life skills: a randomized clinical trial in adolescents with type 1 diabetes.
    Husted GR; Thorsteinsson B; Esbensen BA; Gluud C; Winkel P; Hommel E; Zoffmann V
    Trials; 2014 Aug; 15():321. PubMed ID: 25118146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guided self-determination improves life skills with type 1 diabetes and A1C in randomized controlled trial.
    Zoffmann V; Lauritzen T
    Patient Educ Couns; 2006 Dec; 64(1-3):78-86. PubMed ID: 16720089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insulin delivery devices and glycemic outcomes in young patients with type 1 diabetes: a protocol for a systematic review and meta-analysis.
    Dos Santos TJ; Donado Campos JM; Fraga Medin CA; Argente J; Rodríguez-Artalejo F
    Syst Rev; 2019 Nov; 8(1):259. PubMed ID: 31685014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
    Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
    Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the Association Between Diabetes Distress and Self-Management Behaviors.
    Khan A; Choudhary P
    J Diabetes Sci Technol; 2018 Nov; 12(6):1116-1124. PubMed ID: 30101610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
    Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
    Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
    Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
    Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Young people with type 1 diabetes mellitus: Attitudes, perceptions, and experiences of diabetes management and continuous subcutaneous insulin infusion therapy.
    Perry L; James S; Steinbeck K; Dunbabin J; Lowe J
    J Eval Clin Pract; 2017 Jun; 23(3):554-561. PubMed ID: 28052468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of the Flexible Lifestyles Empowering Change intervention on metabolic and psychosocial outcomes in adolescents with type 1 diabetes (FLEX): a randomised controlled trial.
    Mayer-Davis EJ; Maahs DM; Seid M; Crandell J; Bishop FK; Driscoll KA; Hunter CM; Kichler JC; Standiford D; Thomas JM;
    Lancet Child Adolesc Health; 2018 Sep; 2(9):635-646. PubMed ID: 30119757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
    Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WHICH FACTORS MAY AFFECT THE QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING THE MEDTRONIC VEO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP?
    Thomakos P; Panagopoulos G; Kepaptsoglou O; Zoupas C; Mitrakou A
    Georgian Med News; 2018 Apr; (277):61-67. PubMed ID: 29745917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
    Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
    Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin pump-associated adverse events in children and adolescents--a prospective study.
    Wheeler BJ; Heels K; Donaghue KC; Reith DM; Ambler GR
    Diabetes Technol Ther; 2014 Sep; 16(9):558-62. PubMed ID: 24796368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapy.
    Slijper FM; De Beaufort CE; Bruining GJ; De Visser JJ; Aarsen RS; Kicken DA; Van Strik R
    Diabete Metab; 1990; 16(4):273-7. PubMed ID: 2265733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.